Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients

ClinicalTrials.gov ID: NCT01602367

Public ClinicalTrials.gov record NCT01602367. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 9:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 2B Trial to Evaluate the Safety and Efficacy of BMS-823778 in Overweight and Obese Subjects With Inadequately Controlled Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether BMS-823778 is safe and effective in the treatment of hypertension in overweight and obese patients.

Study identification

NCT ID
NCT01602367
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
7 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2012
Primary completion
Oct 31, 2012
Completion
Oct 31, 2012
Last update posted
Oct 11, 2015

2012

United States locations

U.S. sites
22
U.S. states
12
U.S. cities
21
Facility City State ZIP Site status
Nea Baptist Clinic Jonesboro Arkansas 72401
Local Institution Los Angeles California 90057
Desert Medical Group Inc. Palm Springs California 92262
Local Institution Coral Gables Florida 33134
Local Institution Atlanta Georgia 30303
Pennington Biomedical Research Center Baton Rouge Louisiana 70808-4124
Local Institution New Orleans Louisiana 70115
Anderson And Collins Clinical Research, Inc. Edison New Jersey 08817
Premier Research Trenton New Jersey 08611
Syracuse Preventive Cardiology Syracuse New York 13202-3108
Metrolina Internal Medicine Charlotte North Carolina 28204
Pharmquest, Llc Greensboro North Carolina 27408
Pmg Research Of Salisbury Salisbury North Carolina 28144
Local Institution Shelby North Carolina 28150
Local Institution Shelby North Carolina 28152
Local Institution Winston-Salem North Carolina 27103
Sterling Research Grp, Ltd. Cincinnati Ohio 45246
Local Institution Greenville South Carolina 29615
Local Institution Layton Utah 84041
Manassas Clinical Research Center Manassas Virginia 20110
National Clinical Research - Norfolk, Inc. Norfolk Virginia 23502
National Clinical Research - Richmond, Inc. Richmond Virginia 23294

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01602367, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 11, 2015 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01602367 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →